Activation of Protein Kinase C-ζ by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 Is Defective in Muscle in Type 2 Diabetes and Impaired Glucose ToleranceMary Beeson, Robert V. Farese, Mini P. Sajan et al.|Diabetes|2003Cited by 162
Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjectsVictor M. Luna, Robert V. Farese, L. Casauban et al.|Diabetologia|2006Cited by 50
Combined thiazolidinedione–metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscleN. Temofonte, Robert V. Farese, Mini P. Sajan et al.|Diabetologia|2008Cited by 15
Defective Activation of Protein Kinase C-z in Muscle by Insulin and Phosphatidylinositol-3,4,5,-(PO <sub>4</sub> ) <sub>3</sub> in Obesity and Polycystic Ovary SyndromeMary Beeson, Robert V. Farese, Mini P. Sajan et al.|Metabolic Syndrome and Related Disorders|2004Cited by 13
Contrasting insulin dose-dependent defects in activation of atypical protein kinase C and protein kinase B/Akt in muscles of obese diabetic humansLeanne K. Casaubon, Robert V. Farese, Mini P. Sajan et al.|Diabetologia|2006Cited by 12